Charles J Fisher, Jr

Title: Charles J Fisher, Jr: Innovator in Coronavirus Treatment Technologies

Introduction

Charles J Fisher, Jr. is an accomplished inventor based in Cardiff-by-the-Sea, California. He has made significant contributions to the field of medical technology, particularly in the treatment of coronavirus infections. His innovative approach aims to address the challenges posed by COVID-19 and its lingering effects.

Latest Patents

Fisher holds a patent for "Devices and methods for treating a coronavirus infection and symptoms thereof." This invention focuses on capturing and removing COVID-19 mediating nanoparticles and exosomes from the circulatory system of patients. It is particularly beneficial for those suffering from post-COVID-19 syndrome, also known as 'long haul' symptoms. The patent outlines lectin-based extracorporeal methods that bind and physically remove SARS-CoV-2 virions and non-viral COVID-19 mediating nanoparticles. Additionally, it provides methods for reducing biomarkers associated with morbidity and mortality in diseases like COVID-19.

Career Highlights

Charles J Fisher, Jr. is associated with Aethlon Medical, Inc., a company dedicated to developing innovative medical devices. His work at Aethlon Medical has positioned him as a key player in the fight against COVID-19 and similar diseases. His patent reflects a commitment to improving patient outcomes through advanced medical technologies.

Collaborations

Fisher has collaborated with notable colleagues, including Rosalia De Necochea Campion and Steven P Larosa. These partnerships have contributed to the development and refinement of his innovative medical solutions.

Conclusion

Charles J Fisher, Jr. exemplifies the spirit of innovation in the medical field, particularly in addressing the challenges posed by coronavirus infections. His contributions through patents and collaborations highlight the importance of continued research and development in healthcare technologies.